Bart Meulemans
Impact in
- Cancer Research top 1%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
- Oncology top 10%
Papers in
-
- Childhood Cancer Survivors' Quality of Life 2
-
- Breast Cancer Treatment Studies 2
- Co-authors
- Paul Meijnders (1 shared paper)Michel Henry-Amar (1 shared paper)Hanneke C. Kluin‐Nelemans (1 shared paper)Ivan R. Vogelius (1 shared paper)Berthe M.P. Aleman (1 shared paper)Maja V. Maraldo (1 shared paper)Pierre Feugier (1 shared paper)Francesco Giusti (1 shared paper)
- Journals
- Journal of Clinical Oncology (3 papers)Renal Failure (1 paper)The Lancet Oncology (1 paper)The Breast (1 paper)Hematological Oncology (1 paper)
- Partner nations
- BelgiumFranceNetherlands
In The Last Decade
Bart Meulemans
11 papers receiving 2.1k citations
Bart Meulemans's Hit Papers
Peers
Comparison fields: 5 of 63
- Cancer Research 1.3k
- Oncology 196
- Pathology and Forensic Medicine 136
- Dermatology 65
- Health Informatics 14
Countries citing papers authored by Bart Meulemans
This map shows the geographic impact of Bart Meulemans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bart Meulemans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bart Meulemans more than expected).
Fields of papers citing papers by Bart Meulemans
This network shows the impact of papers produced by Bart Meulemans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bart Meulemans. The network helps show where Bart Meulemans may publish in the future.
Co-authors
The 25 scholars most cited alongside Bart Meulemans, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer Hit paper breakdown → | 2016 | 1431 |
| 2 | 70-gene signature as an aid for treatment decisions in early breast cancer: updated results of the phase 3 randomised MINDACT trial with an exploratory analysis by age Hit paper breakdown → | 2021 | 255 |
| 3 | 2015 | 137 | |
| 4 | 2011 | 106 | |
| 5 | 2012 | 65 | |
| 6 | 2012 | 32 | |
| 7 | 2023 | 32 | |
| 8 | 2013 | 28 | |
| 9 | 2022 | 17 | |
| 10 | 2004 | 7 | |
| 11 | 2018 | 5 | |
| 12 | 2023 | 0 |
About Bart Meulemans
Bart Meulemans is a scholar working on Pediatrics, Perinatology and Child Health, Cancer Research, Pathology and Forensic Medicine, Public Health, Environmental and Occupational Health and Oncology, having authored 12 papers that have together received 2.1k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (2 papers), Breast Cancer Treatment Studies (2 papers), Reproductive Biology and Fertility (2 papers), Childhood Cancer Survivors' Quality of Life (2 papers), Chemotherapy-induced cardiotoxicity and mitigation (1 paper), Antioxidant Activity and Oxidative Stress (1 paper), Redox biology and oxidative stress (1 paper) and Cancer survivorship and care (1 paper). The work is most often cited by research in Cancer Research (1.3k citations), Oncology (196 citations), Pathology and Forensic Medicine (136 citations), Dermatology (65 citations) and Health Informatics (14 citations). Bart Meulemans has collaborated with scholars based in Belgium, France and Netherlands. Frequent co-authors include Paul Meijnders, Michel Henry-Amar, Hanneke C. Kluin‐Nelemans, Ivan R. Vogelius, Berthe M.P. Aleman, Maja V. Maraldo, Pierre Feugier, Francesco Giusti, Lena Specht and Safaa Mahmoud Ramadan. Their work appears in journals such as Journal of Clinical Oncology, Renal Failure, The Lancet Oncology, The Breast and Hematological Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.